-
Home
/
-
Vol 3 (December 2020)
/
- Pembrolizumab and immunotherapy in advanced hepatocellular carcinoma: an evaluation of KEYNOTE-240
Editorial Commentary
Pembrolizumab and immunotherapy in advanced hepatocellular carcinoma: an evaluation of KEYNOTE-240
Amy Lee, Fa-Chyi Lee